• Home
  • About ISDB
    • What is ISDB?
    • Committee
    • Constitution
  • How to join
    • COI-forms
    • Criteria for membership
    • Application forms
  • Members
    • Bulletin index
    • Full members
    • Associated members
  • Publications
    • Newsletters
    • ISDB Publications
    • Press releases
    • Documents of interest
  • Campaigns
    • Working groups
    • Petitions
    • Future meetings
    • Past meetings
  • Intranet

ISDB – International Society of Drug Bulletins

International Society of Drug Bulletins

  • Home
  • About ISDB
    • What is ISDB?
    • Committee
    • Constitution
  • How to join
    • COI-forms
    • Criteria for membership
    • Application forms
  • Members
    • Bulletin index
    • Full members
    • Associated members
  • Publications
    • Newsletters
    • ISDB Publications
    • Press releases
    • Documents of interest
  • Campaigns
    • Working groups
    • Petitions
    • Future meetings
    • Past meetings
  • Intranet
  • Menu

European Medicines Agency and pharmacovigilance: no to a fee-for-service system

September 15, 2012 Campaigns

Regrettably, the European Medicines Agency (EMA) is being turned into a mere provider of services to the pharmaceutical industry. Other strategies for funding that would help drug regulatory agencies to be more independent do exist. They should be carefully considered.

 
read (280 KB)

Recent Publications

  • ISDB Newsletter October 2023
  • ISDB response to the public consultation on the Clinical Trials Regulation and its information system
  • ISDB Newsletter April 2023
  • Information on Covid-19
  • Response letter of the Australian Health Minister in follow-up of ISDB mobilization in support of Australian Prescriber

Newsletter

Recent Campaigns

  • Letter to the Australian Health Minister in support of Australian Prescriber
  • Letter to Charles Michel on transparency in EU institutions
  • A letter to the Prime Minister of India
  • ISDB General Assembly Paris 2019
  • News from working groups: Clinical Study Reports?

Contact

President
Rita Kessler
president@isdbweb.org

Webmaster
deToon
tjvandort@gmail.com

Sign up to receive our newsletter.

Press releases

  • Statement: COVID-19 [EN]
  • ISDB General Assembly Paris 2019
  • Cochrane’s sinking ship and conflicts of interest
  • No to EMA’s provision of confidential scientific advice to drug companies (November 2017)
  • Supplementary protection certificates (SPCs) delay access to affordable medicines (September 2017)

Newsletters

  • ISDB Newsletter October 2023
  • ISDB Newsletter April 2023
  • ISDB Newsletter September 2022
  • ISDB Newsletter December 2021
  • ISDB Newsletter August 2021

© 2023 ISDB – International Society of Drug Bulletins.